Get started
Xenetic Biosciences, Inc.Xenetic Biosciences, Inc.Xenetic Biosciences, Inc.

Xenetic Biosciences, Inc.

No trades
No trades
OverviewFinancialsFilingsNewsCommunityTechnicalsSeasonals
Full chart
Full chart

Compare with Xenetic Biosciences, Inc.



Key stats


Market capitalization
‪4.83 M‬ USDNano cap
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−1.19 USD
Net income (FY)
‪−2.68 M‬ USD
Revenue (FY)
‪2.98 M‬ USD
Shares float
‪1.98 M‬
Beta (1Y)
1.52

Upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Employees


Employees (FY)
2
Change (1Y)
0
Revenue / Employee (1Y)
‪1.49 M‬ USD
Net income / Employee (1Y)
‪−1.34 M‬ USD

Company info


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
James F. Parslow
Website
xeneticbio.com
Headquarters
Framingham
Founded
2011
IPO date
Nov 7, 2016
ISIN
US9840156023
CUSIP
984015602
FIGI
BBG0028WJXC0
Identifiers
ISIN US9840156023
CFI code
ESVUFR
Xenetic Biosciences, Inc. is a biopharmaceutical company engaged in the advancement of cell-based therapeutics to target the B-cell receptor on the surface of an individual patient’s malignant tumor cells. Its product pipeline includes XCart Platform and Polyxen. The company was founded on August 9, 2011 and is headquartered in Framingham, MA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Oscillators
Neutral
Oscillators
Neutral
Summary
Neutral
Summary
Neutral
Summary
Neutral
Moving Averages
Neutral
Moving Averages
Neutral

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently asked questions


Xenetic Biosciences, Inc. is scheduled to release its next earnings report on Nov 6, 2026.

Why it matters:
– Key event: Earnings often drive significant price moves
– Market expectations: Traders watch revenue, EPS, and guidance vs forecasts
– Volatility spike: Price swings can increase before and after the release

How to use it:
– Track upcoming reports in the Earnings Calendar
– Compare actual results with analyst estimates
– Monitor price reaction and volume on Supercharts
XBIO stock is 6.33% volatile and has beta coefficient of 1.52.

What it means:
– Volatility: Shows how much the price fluctuates over time
– Beta > 1: More volatile than the market
– Beta < 1: Less volatile, more stable

Important to know:
– Volatility can increase during earnings, news events, or market stress
– Large-cap stocks like XBIO are typically less volatile than smaller companies

Track every detail on Xenetic Biosciences, Inc. stock chart and check out the list of the most volatile stocks — is Xenetic Biosciences, Inc. there?
To understand the XBIO stock performance, it's worth checking price changes for various periods to get the full picture:
– 1 day — +2.80%
– 1 week — +16.99%
– 1 month — −7.93%

XBIO all-time low was 1.58 USD (Oct 26, 2026), and its highest price is 39,603.96 USD (Jan 31, 2014). Find more dynamics in the Stock Heatmap and on the Xenetic Biosciences, Inc. stock chart.
Xenetic Biosciences, Inc. market capitalization is ‪4.83 M‬, representing the total value of all its outstanding shares (price × shares outstanding).

What it means:
– Market cap is one of the key ways to classify companies (large-cap, mid-cap, etc.)
– It reflects how investors value the company today
– It changes constantly with stock price movements

What to look at next:
– Market cap trends: Rising cap may signal growth and investor confidence; falling cap can reflect risk or downturns
– Price vs shares: Changes can come from Xenetic Biosciences, Inc. stock price moves or share count (buybacks, issuance)
– Valuation ratios: Compare market cap with revenue and earnings
– Peer comparison: See how Xenetic Biosciences, Inc. stacks up against other companies
The safest way to buy Xenetic Biosciences, Inc. stocks is through a reliable broker. Create an account, fund it, and place a buy order.

You can trade XBIO directly from TradingView:
– Choose a broker: Explore our supported trading partners and pick one that fits your needs
– Compare options: View available brokers side by side to evaluate fees and features
– Connect your account: Open Supercharts, click “Trade”, select your broker, and log in
– Start trading: Place orders without leaving the chart

Tip: If you’re new to trading, try paper trading first — it lets you practice strategies in real market conditions without risking funds.
As of Nov 4, 2026, the company has 2 employees.

Why traders follow this data:
– Company scale: Employee count reflects the size and global reach of the business
– Operational footprint: Higher headcount often indicates broader product lines, retail presence, or services
– Trend signal: Changes over time can reflect hiring growth, restructuring, or efficiency improvements

See our rating of the largest employers to find more opportunities.
Investing in Xenetic Biosciences, Inc. depends on your goals, risk tolerance, and market conditions. It’s essential to analyze the stock before making a decision.

First, study Xenetic Biosciences, Inc. financials and track their dynamics on the Fundamental Graphs:
– Business fundamentals: Revenue, earnings, and growth trends
– Valuation: P/E ratio, market cap, and how it compares to peers
– Profitability: Margins, return on equity, and cash flow
– Dividends (if any): Yield, payout ratio, and consistency

Then explore our XBIO technicals – signals based on essential indicators calculations:
– Today — sell
– 1-week — sell
– 1-month — sell

Combine fundamental and technical analysis for better results.
Xenetic Biosciences, Inc. stock ticker depends on the exchange where it’s listed. On the NASDAQ, its primary exchange, Xenetic Biosciences, Inc. stocks trade under the symbol XBIO.

About tickers:
– Unique identifiers: A ticker is a short code used to find and trade a stock
– Exchange-specific: The same company may have different tickers across exchanges
– Search shortcut: Used on trading platforms, charts, and screeners

Remember:
– Some companies have multiple listings
– Always check the exchange prefix to avoid confusion

Learn how to find your desired assets in our Symbol Search.
Yes, you can track Xenetic Biosciences, Inc. financials in yearly and quarterly reports right on TradingView.

Use our Earnings Calendar to never miss important releases and spot opportunities early.
XBIO net income for the last quarter is ‪−929.70 K‬ USD, while the quarter before that showed ‪−456.38 K‬ USD of net income which accounts for −103.71% change.

How to read this data:
– Track changes: Compare net income across quarters to spot trends
– Watch expectations: Compare with estimates to gauge performance
– Check margins: Net income reflects profitability after all expenses
– Look beyond one quarter: Consistency matters more than a single result

Follow other essential metrics in Xenetic Biosciences, Inc. financials:
– Revenue: Overall business growth
– Earnings per share: Rising EPS over time often points to improving business performance
– Margins (gross, operating): Efficiency and cost control
No, Xenetic Biosciences, Inc. does not currently pay dividends to its shareholders.

Instead of distributing profits as cash payments, the company may choose to reinvest earnings back into the business — for example, in growth, innovation, acquisitions, or debt reduction.

What to consider instead:
– Earnings growth: Is the company increasing profitability over time?
– Revenue expansion: Is the business scaling its operations?
– Free cash flow: Does it generate enough cash to potentially support future dividends?
– Share buybacks: Some companies return capital through repurchasing shares instead of dividends
XBIO reached its all-time high of 39,603.96 USD on Jan 31, 2014. Its all-time low was 1.58 USD and was reached on Oct 26, 2026.

Explore the Xenetic Biosciences, Inc. stock price chart to see more price history, and discover companies reaching new all-time highs and lows.
Xenetic Biosciences, Inc. EBITDA is ‪−2.64 M‬ USD, with an EBITDA margin of −95.23%.

EBITDA is a measure of core operating performance, showing how much profit the company generates from its main business activities before accounting for financing and accounting-related costs.

What it means:
– Operating strength: Helps assess profitability from core operations
– Efficiency signal: Rising EBITDA often reflects improving business performance
– Comparability: Useful for comparing companies with different capital structures

What to look at next in Xenetic Biosciences, Inc. statements:
– Revenue growth: Shows whether the business is expanding
– Net income: Captures full profitability after all expenses
– Free cash flow: Shows actual cash generated
– Debt levels: Important when evaluating earnings quality